Pediatric eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children worldwide. Dr. Hannah Kopelman and Dr. Lawrence F. Eichenfield discuss the latest advancements in managing pediatric eczema. They explore new treatment options like SOTYKTU, Adbry, and JAK inhibitors/biologics, focusing on symptom management and comprehensive care. The discussion highlights the promise of drugs such as Dupixent and lebrikizumab, the importance of individualized treatment plans, and the need for ongoing research to better understand the causes of eczema and develop prevention strategies and potential cures.

Guest Bio:

Dr. Lawrence F. Eichenfield is a distinguished pediatric dermatologist at Rady Children's Hospital in San Diego, specializing in eczema and autoimmune skin disorders. With extensive experience in clinical practice and research, he has significantly advanced pediatric dermatology.

Connect with me across Social: Instagram:https://www.instagram.com/drhannahkopelman/ TikTok: https://www.tiktok.com/@drhankopelman Twitter: https://twitter.com/drhankopelman Pinterest: https://www.pinterest.com/drhankopelman/ Blog: https://www.hannahkopelman.com/blog/ The content of this podcast is for entertainment and educational purposes only. This content is not meant to be a substitute for medical advice or treatment for any medical condition.